New flu shot aims to protect against more strains
NCT ID NCT04210349
Summary
This study tested a new flu vaccine designed to protect against four strains of influenza, comparing it to standard vaccines that protect against three strains. It involved over 7,000 participants in China, from infants as young as 6 months to adults over 65. The main goals were to see if the new vaccine triggered a similar or better immune response and to check its safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number 1561000
Kunming, 650022, China
-
Investigational Site Number 1561001
Lincang, 677001, China
-
Investigational Site Number 1561002
Lincang, 677001, China
-
Investigational Site Number 1561003
Lincang, 677001, China
-
Investigational Site Number 1562000
Zhengzhou, 450002, China
-
Investigational Site Number 1562001
Shangqiu, 476000, China
-
Investigational Site Number 1562002
Xinxiang, 453200, China
Conditions
Explore the condition pages connected to this study.